RhumbLine Advisers’s Neuropace NPCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $412K | Buy |
36,956
+19,729
| +115% | +$220K | ﹤0.01% | 2802 |
|
|
2025
Q1 | $212K | Buy |
17,227
+2,267
| +15% | +$27.9K | ﹤0.01% | 3078 |
|
|
2024
Q4 | $167K | Buy |
14,960
+634
| +4% | +$7.09K | ﹤0.01% | 3284 |
|
|
2024
Q3 | $99.8K | Sell |
14,326
-338
| -2% | -$2.36K | ﹤0.01% | 3495 |
|
|
2024
Q2 | $111K | Buy |
+14,664
| New | +$111K | ﹤0.01% | 3489 |
|